BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 9045386)

  • 1. [Activation of cellular immunity in Wegener's granulomatosis: a study of neopterin, interleukin-2 receptors and tumor necrosis factor].
    Nasonov EL; Samsonov MIu; Tilz GP; Beketova TV; Semenkova EN; Mukhin NA; Baranov AA; Wachter H; Fuchs D
    Ter Arkh; 1996; 68(11):67-70. PubMed ID: 9045386
    [No Abstract]   [Full Text] [Related]  

  • 2. Serum concentrations of neopterin, soluble interleukin 2 receptor, and soluble tumor necrosis factor receptor in Wegener's granulomatosis.
    Nassonov EL; Samsonov MY; Tilz GP; Beketova TV; Semenkova EN; Baranov A; Wachter H; Fuchs D
    J Rheumatol; 1997 Apr; 24(4):666-70. PubMed ID: 9101499
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Immunological methods for assessing the activity of necrotizing vasculitis (Wegener's granulomatosis and microscopic polyarteritis) with kidney involvement].
    Beketova TV; Nasonov EL; Semenkova EN; Kozlovskaia LV; Aleksandrova EN; Tishchenko VA; Samsonov MIu; Baranov AA
    Ter Arkh; 1996; 68(6):50-2. PubMed ID: 8771686
    [No Abstract]   [Full Text] [Related]  

  • 4. Plasma elastase-alpha 1-antitrypsin, neopterin, tumor necrosis factor, and soluble interleukin-2 receptor after prolonged exercise.
    Dufaux B; Order U
    Int J Sports Med; 1989 Dec; 10(6):434-8. PubMed ID: 2628363
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Wegener's granulomatosis.
    Lamprecht P; Gross WL
    Herz; 2004 Feb; 29(1):47-56. PubMed ID: 14968341
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Cellular immunity in pregnancy-induced hypertensive diseases].
    Schröcksnadel H; Herold M; Steckel-Berger G; Fuchs D; Wachter H; Dapunt O
    Geburtshilfe Frauenheilkd; 1992 Oct; 52(10):592-5. PubMed ID: 1294433
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Serum neopterin concentrations in Wegener's granulomatosis correlate with vasculitis activity.
    Nassonov E; Samsonov M; Beketova T; Semenkova L; Wachter H; Fuchs D
    Clin Exp Rheumatol; 1995; 13(3):353-6. PubMed ID: 7554564
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Cytokines in extracorporeal circulation].
    Giordano G; Pignatelli MG; Biancardi L; Castenetto E; Vai M; Cavalli G; Polloni R; Ferro M; Amprimo MC; Roccatello D
    Minerva Anestesiol; 1991 Oct; 57(10):1020-1. PubMed ID: 1961455
    [No Abstract]   [Full Text] [Related]  

  • 9. Lymphocyte activation markers and von Willebrand factor antigen in Wegener's granulomatosis: potential markers for disease activity.
    D'Cruz D; Direskeneli H; Khamashta M; Hughes GR
    J Rheumatol; 1999 Jan; 26(1):103-9. PubMed ID: 9918249
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The spectrum of Wegener's granulomatosis and disease relapse.
    Bacon PA
    N Engl J Med; 2005 Jan; 352(4):330-2. PubMed ID: 15673799
    [No Abstract]   [Full Text] [Related]  

  • 11. [Antineutrophil cytoplasmic antibodies in 2 patients with Wegener's granulomatosis].
    Larraga R; Manero FJ; Bell S; Herrero Y; Chacón E; Hernández A
    An Med Interna; 1998 Oct; 15(10):538-40. PubMed ID: 9844230
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Neopterin levels in plasma during a longitudinal study in an area endemic for malaria.
    Picot S; Peyron F; Vuillez JP; Barbe G; Deloron P; Jacob MC; Chumpitazi B; Boudin C; Sheik-Zakkiudin I; Ambroise-Thomas P
    Clin Immunol Immunopathol; 1993 Jun; 67(3 Pt 1):273-6. PubMed ID: 8500275
    [TBL] [Abstract][Full Text] [Related]  

  • 13. ANCA are detectable in nearly all patients with active severe Wegener's granulomatosis.
    Finkielman JD; Lee AS; Hummel AM; Viss MA; Jacob GL; Homburger HA; Peikert T; Hoffman GS; Merkel PA; Spiera R; St Clair EW; Davis JC; McCune WJ; Tibbs AK; Ytterberg SR; Stone JH; Specks U;
    Am J Med; 2007 Jul; 120(7):643.e9-14. PubMed ID: 17602941
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Excessive interleukin-15 transpresentation endows NKG2D+CD4+ T cells with innate-like capacity to lyse vascular endothelium in granulomatosis with polyangiitis (Wegener's).
    de Menthon M; Lambert M; Guiard E; Tognarelli S; Bienvenu B; Karras A; Guillevin L; Caillat-Zucman S
    Arthritis Rheum; 2011 Jul; 63(7):2116-26. PubMed ID: 21484763
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Current state of tumour necrosis factor {alpha} blockade in Wegener's granulomatosis.
    Mukhtyar C; Luqmani R
    Ann Rheum Dis; 2005 Nov; 64 Suppl 4(Suppl 4):iv31-6. PubMed ID: 16239383
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Th1 and Th2 CD4+ T cells and Tc1 and Tc2 CD8+ T cells of patients with Wegener's granulomatosis.
    Ohta N; Fukase S; Fuse T; Aoyagi M
    J Laryngol Otol; 2002 Aug; 116(8):605-9. PubMed ID: 12389688
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Diagnosis of Wegener's granulomatosis in the ANCA era.
    Al Maini M; Carette S
    J Rheumatol; 2006 Oct; 33(10):1923-5. PubMed ID: 17014008
    [No Abstract]   [Full Text] [Related]  

  • 18. Monitoring of tumor necrosis factor therapy with neopterin.
    Peters KM; Dommaschk J; Grundmann R; Schaadt M; Schicha H
    Arzneimittelforschung; 1990 Apr; 40(4):508-10. PubMed ID: 2357253
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical and immunological aspects of Wegener's granulomatosis (WG) and other syndromes resembling WG.
    Lamprecht P; Trabandt A; Gross WL
    Isr Med Assoc J; 2000 Aug; 2(8):621-6. PubMed ID: 10979359
    [No Abstract]   [Full Text] [Related]  

  • 20. [Neopterin and interleukin 2 soluble receptors as biochemical markers of cellular immune response to surgical trauma].
    Delogu G; Reale G; Marchei GG; Rezaeieh RH; Casula MA; Reale C; Signore L; Martinelli V
    Ann Ital Chir; 1992; 63(3):359-62; discussion 363. PubMed ID: 1444001
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.